AJP - Lung Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (January 29, 2004). doi:10.1152/ajplung.00427.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/6/L1194    most recent
00427.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Everett, A. D.
Right arrow Articles by Tucker, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Everett, A. D.
Right arrow Articles by Tucker, A.
Submitted on December 3, 2003
Accepted on January 27, 2004

Hepatoma Derived Growth Factor is a Pulmonary Endothelial Cell Expressed Angiogenic Factor

Allen D. Everett1*, Jill V. Narron2, Tamara Stoops2, Hideji Nakamura3, and Amy Tucker4

1 Department of Pediatrics, Division Pediatric Cardiology, University of Virginia Health System, Charlottesville, VA, USA; Department of Internal Medicine, Cardiology Division, University of Virginia Health System, Charlottesville, VA, USA
2 Department of Pediatrics, Division Pediatric Cardiology, University of Virginia Health System, Charlottesville, VA, USA
3 Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan
4 Department of Internal Medicine, Cardiology Division, University of Virginia Health System, Charlottesville, VA, USA

* To whom correspondence should be addressed. E-mail: aeveret3{at}jhmi.edu.

Hepatoma derived growth factor (HDGF) was previously identified as a developmentally regulated cardiovascular and renal gene that is mitogenic for vascular smooth muscle and aortic endothelial cells. As reciprocal interactions of smooth muscle and endothelial cells are necessary for vascular formation, we examined whether HDGF plays a role in angiogenesis. Using immunohistochemistry, HDGF was highly expressed in endothelial cells of non-muscularized, forming blood vessels of the fetal lung. HDGF was also expressed in endothelial cells of small (20 µm) mature arteries and veins. By Western immuno-blotting, HDGF was highly expressed by human pulmonary microvascular endothelial cells in vitro. Adenoviral overexpression of HDGF was mitogenic for human pulmonary microvascular endothelial cells in serum free media, stimulating a 1.75 fold increase in BrdU uptake and a two fold increase in cell migration. Using the chick chorioallantoic membrane (CAM) a biologic assay for angiogenesis, exogenous recombinant HDGF significantly stimulated blood vessel formation and a dose dependent reorganization of cells within the CAM into a more compact, linear alignment reminiscent of tube formation. Using double immunostaining for endothelial cells with a TGFBIIR antibody and BrdU as a marker of cell proliferation, exogenous HDGF selectively stimulated endothelial cell BrdU uptake. HDGF also activated specific Erk1/2 signaling and did not overlap with VEGF SAPK/JNK, Akt mediated pathways. We conclude that HDGF is a highly expressed vascular endothelial cell protein in vivo and is a potent endothelial mitogen and regulator of endothelial cell migration by mechanisms distinct from VEGF.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
S. Yamamoto, Y. Tomita, Y. Hoshida, E. Morii, T. Yasuda, Y. Doki, K. Aozasa, H. Uyama, H. Nakamura, and M. Monden
Expression Level of Hepatoma-Derived Growth Factor Correlates with Tumor Recurrence of Esophageal Carcinoma
Ann. Surg. Oncol., July 1, 2007; 14(7): 2141 - 2149.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Uyama, Y. Tomita, H. Nakamura, S. Nakamori, B. Zhang, Y. Hoshida, H. Enomoto, Y. Okuda, M. Sakon, K. Aozasa, et al.
Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Patients with Pancreatic Cancer.
Clin. Cancer Res., October 15, 2006; 12(20): 6043 - 6048.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
S. M. Lukasik, T. Cierpicki, M. Borloz, J. Grembecka, A. Everett, and J. H. Bushweller
High resolution structure of the HDGF PWWP domain: A potential DNA binding domain
Protein Sci., February 1, 2006; 15(2): 314 - 323.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zhang, H. Ren, P. Yuan, W. Lang, L. Zhang, and L. Mao
Down-regulation of Hepatoma-Derived Growth Factor Inhibits Anchorage-Independent Growth and Invasion of Non-Small Cell Lung Cancer Cells
Cancer Res., January 1, 2006; 66(1): 18 - 23.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Abouzied, H. M. El-tahir, L. Prenner, H. Haberlein, V. Gieselmann, and S. Franken
Hepatoma-derived Growth Factor: SIGNIFICANCE OF AMINO ACID RESIDUES 81-100 IN CELL SURFACE INTERACTION AND PROLIFERATIVE ACTIVITY
J. Biol. Chem., March 25, 2005; 280(12): 10945 - 10954.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.